These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 946473)

  • 1. Editorial: Sudden death and lingering hope.
    Vaisrub S
    JAMA; 1976 Apr; 235(16):1726. PubMed ID: 946473
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Prehospital ventricular defibrillation.
    Rapaport E
    N Engl J Med; 1974 Aug; 291(7):358-9. PubMed ID: 4851548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sudden heart death in ventricular heart rhythm disorders: possibilities and limits of long-term therapy].
    Lüderitz B; Manz M; Steinbeck G
    Internist (Berl); 1984 Jul; 25(7):415-20. PubMed ID: 6147323
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction and prevention of sudden cardiac death in myocardial ischaemia. Round table discussion by mail.
    Adgey AA; Günther KH; Kalusche D; Lown B; Mazur NA; Oliver MF; Takác M; Varnauskas E; Fejfar Z
    Cor Vasa; 1986; 28(2):138-54. PubMed ID: 3731788
    [No Abstract]   [Full Text] [Related]  

  • 5. [When is arrhythmia therapy indicated?].
    Gahl K
    MMW Munch Med Wochenschr; 1980 Jan; 122(3):79-80. PubMed ID: 6154234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of cicletanine on a sudden death model in dogs].
    Guillon JM; Thievant P; Braquet P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():151-4. PubMed ID: 2514657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic therapy for survivors of sudden death based on programmed stimulation.
    Roy D; Marchlinski FE; Doherty JU; Buxton AE; Josephson ME
    Cardiovasc Clin; 1985; 15(3):179-85. PubMed ID: 3914364
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in antiarrhythmic drug therapy--changing concepts. Introduction.
    Kaplan HR
    Fed Proc; 1986 Jul; 45(8):2184-5. PubMed ID: 3720961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-arrhythmic therapy of ventricular arrhythmias. Assessing benefit and risk].
    Haberl R; Steinbeck G
    Internist (Berl); 1993 May; 34(5):436-43. PubMed ID: 8509254
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiarrhythmia agents in heart failure].
    Duc P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):595-8. PubMed ID: 7487307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary ventricular fibrillation: a reason to be cautious.
    Jordaens LJ; T Kindt H
    Eur Heart J; 1997 Jun; 18(6):890-2. PubMed ID: 9183575
    [No Abstract]   [Full Text] [Related]  

  • 12. Arrhythmias and antiarrhythmic agents.
    Heddle WF; Tonkin AM
    Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J; Kerr C; Teo K
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract]   [Full Text] [Related]  

  • 14. New concepts and approaches to sudden cardiac death.
    Lown B
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1522-31. PubMed ID: 1013667
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary preventive trials with antiarrhythmic agents: are we asking the right question?
    Lubsen J
    Eur Heart J; 1984 Sep; 5 Suppl B():109-11. PubMed ID: 6499868
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
    ; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ;
    J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478
    [No Abstract]   [Full Text] [Related]  

  • 18. Sudden death in the mitral valve prolapse-click syndrome.
    Jeresaty RM
    Am J Cardiol; 1976 Feb; 37(2):317-8. PubMed ID: 1108636
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Recurrent "sudden death".
    Warren JV
    N Engl J Med; 1975 Aug; 293(6):298-9. PubMed ID: 1138182
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiarrhythmic drugs in prevention of recurrent ventricular fibrillation].
    Szmydt W; Brodzińska K; Luczak J
    Pol Tyg Lek; 1971 Jan; 26(3):99-101. PubMed ID: 5545841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.